Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,472.00
Bid: 12,492.00
Ask: 12,496.00
Change: 74.00 (0.60%)
Spread: 4.00 (0.032%)
Open: 12,432.00
High: 12,526.00
Low: 12,318.00
Prev. Close: 12,398.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

In Senegal, lack of cold storage limits COVID vaccine options

Mon, 11th Jan 2021 17:09

By Christophe Van Der Perre

DAKAR, Jan 11 (Reuters) - Senegal does not have the capacity
to store COVID-19 vaccines at ultra-low temperatures and would
prefer to receive vials that can be kept for longer under
ordinary refrigeration, the head of the country's vaccination
programme said on Monday.

A lack of cold storage means Senegal would only be able to
keep vaccines developed by AstraZeneca and Oxford
University, by China or Russia in the long term, as they do not
require a deep freeze, Ousseynou Badiane told Reuters.

Those being distributed by Moderna, which require
storage at minus 20 degrees Celsius (-4 F), and Pfizer
and BioNTech, which need to be kept at -70 degrees
Celsius, are less desirable. Senegal could store the Moderna
vaccine for 30 days and the Pfizer one for seven days but after
that they would be spoiled, Badiane added.

The Moderna and Pfizer vaccines "are not our first choice.
Our first choice is the vaccine that fits easily into the system
that exists, that doesn't require major investment," Badiane
told Reuters.

"If the vaccines are not used (in the right time frame) that
would be an enormous waste."

The situation in Senegal highlights the problems that poorer
countries with hot climates face in storing and distributing
vaccines, often in rural areas with unreliable power supplies.

It also shows how far behind some African countries are in
preparing to receive vaccines even as COVID-19 cases surge to
record levels.

Millions have already received inoculations in Western
countries and China, while Senegal is awaiting vaccines through
the World Health Organization-backed global COVAX scheme. This
programme is helping to finance deliveries to 92 developing
nations with limited or no means to buy vaccines on their own.

Senegal is no stranger to vaccination campaigns.

In four walk-in cold rooms in the capital Dakar, authorities
keep thousands of vials of yellow fever and hepatitis B vaccines
at between 2 and 8 degrees Celsius. It has one room that keeps
oral polio vaccines up to minus 25 degrees Celsius.

At the Fann hospital in Dakar, technicians are installing
seven new such rooms. But for now the lack of deep refrigeration
limits the country's options.

"If the option now is to take the (Pfizer or Moderna)
vaccines we... would have to redo all our logistics," Badiane
said.
(Writing by Edward McAllister;
Editing by Hereward Holland and Gareth Jones)

More News
29 Jan 2024 08:19

TOP NEWS: AstraZeneca, Daiichi's Enhertu granted priority review in US

(Alliance News) - AstraZeneca PLC on Monday said its cancer drug conjugate received priority review by the Food & Drug Administration in the US for patients with metastatic HER2-positive solid tumours.

Read more
22 Jan 2024 11:45

BioNTech challenges AstraZeneca with breast cancer precision drug trial

FRANKFURT, Jan 22 (Reuters) - BioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing their precision drug against a certain type of breast cancer, taking on a rival partnership between AstraZeneca and Daiichi Sankyo.

Read more
19 Jan 2024 09:28

TOP NEWS: AstraZeneca's Voydeya receives approval in Japan for PNH

(Alliance News) - AstraZeneca PLC on Friday said its inhibitor Voydeya, also known as danicopan, received approval in Japan for adults with paroxysmal nocturnal haemoglobinuria, or PNH.

Read more
16 Jan 2024 17:17

FTSE 100 hits one-month low, precious miners biggest drag

FTSE 100 down 0.5%, FTSE 250 flat

*

Read more
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.